P09250 (KITH_VZVD) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 60.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Thymidine kinase EC=2.7.1.21 | ||
| Gene names |
| ||
| Organism | Varicella-zoster virus (strain Dumas) (HHV-3) (Human herpesvirus 3) [Reference proteome] | ||
| Taxonomic identifier | 10338 [NCBI] | ||
| Taxonomic lineage | Viruses › dsDNA viruses, no RNA stage › Herpesvirales › Herpesviridae › Alphaherpesvirinae › Varicellovirus › ![]() | ||
| Virus host | Homo sapiens (Human) [TaxID: 9606] |
Protein attributes
| Sequence length | 341 AA. |
| Sequence status | Complete. |
| Protein existence | Inferred from homology |
General annotation (Comments)
| Function | In latent infection, may allow the virus to be reactivated and to grow in cells lacking a high concentration of phosphorylated nucleic acid precursors, such as nerve cells that do not replicate their genome By similarity. |
| Catalytic activity | ATP + thymidine = ADP + thymidine 5'-phosphate. |
| Subunit structure | Homodimer By similarity. |
| Miscellaneous | Phosphorylates and thereby activates certain drugs like acyclovir (ACV), valacyclovir, and famciclovir to a toxic form, that leads to successful suppression of the infection, while the uninfected cell does not have this ability because it lacks TK. Mutations in thymidine kinase may induce HSV resistance to antiviral therapies in immunocompromised patients. The most frequently observed resistant strains are unable to express TK and are avirulent in animal models of disease. Resistance may be acquired less frequently by selecting variants which no longer recognize ACV or ACV triphosphate as substrates but which retain normal functions By similarity. |
| Sequence similarities | Belongs to the herpesviridae thymidine kinase family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | DNA synthesis |
| Developmental stage | Early protein |
| Ligand | ATP-binding Nucleotide-binding |
| Molecular function | Kinase Transferase |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | DNA replication Inferred from electronic annotation. Source: UniProtKB-KW TMP biosynthetic processInferred from electronic annotation. Source: InterPro |
| Molecular_function | ATP binding Inferred from electronic annotation. Source: UniProtKB-KW thymidine kinase activityInferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 341 | 341 | Thymidine kinase | PRO_0000175084 | |||||
Regions | |||||||||
| Nucleotide binding | 19 – 26 | 8 | ATP Potential | ||||||
Sites | |||||||||
| Active site | 48 | 1 | Proton acceptor Potential | ||||||
| Binding site | 66 | 1 | Substrate By similarity | ||||||
| Binding site | 90 | 1 | Substrate By similarity | ||||||
| Binding site | 139 | 1 | Substrate By similarity | ||||||
| Binding site | 183 | 1 | ATP By similarity | ||||||
Natural variations | |||||||||
| Natural variant | 130 | 1 | R → Q in strain: Isolate 7-1-3. | ||||||
| Natural variant | 154 | 1 | L → P in strain: Isolate 40a2. | ||||||
| Natural variant | 288 | 1 | S → L in strain: Ellen, ppIIa, Isolate clinical GK, Isolate 7-1-3, Isolate 101 and Isolate 3-5-2/KB3. | ||||||
| Natural variant | 319 | 1 | A → V in strain: Isolate clinical GK. | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The complete DNA sequence of varicella-zoster virus." Davison A.J., Scott J.E. J. Gen. Virol. 67:1759-1816(1986) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [2] | "Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus." Sawyer M.H., Inchauspe G., Biron K.K., Waters D.J., Straus S.E., Ostrove J.M. J. Gen. Virol. 69:2585-2593(1988) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. Strain: Ellen, Isolate 101, Isolate 3-5-2/KB3, Isolate 40a2, Isolate 7-1-3, isolate clinical GK and ppIIa. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | X04370 Genomic DNA. Translation: CAA27919.1. |
| PIR | KIBE36. A27341. KIBEEL. A28930. KIBE73. B28930. KIBEGK. E28930. |
3D structure databases | |
| ProteinModelPortal | P09250. |
| SMR | P09250. Positions 8-338. |
| ModBase | Search... |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Phylogenomic databases | |
| ProtClustDB | PHA3138. |
Family and domain databases | |
| InterPro | IPR001889. Herpes_TK. [Graphical view] |
| Pfam | PF00693. Herpes_TK. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | P09250. |
| ChEMBL | CHEMBL4784. |
| DrugBank | DB00194. Vidarabine. |
Entry information
| Entry name | KITH_VZVD | ||||||||
| Accession | Primary (citable) accession number: P09250 Secondary accession number(s): O57298 P14344 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Viral Protein Annotation Program | ||||||||
Relevant documents
| SIMILARITY comments Index of protein domains and families |

Clusters with
